Eldridge Investment Advisors, Inc. Abb Vie Inc. Transaction History

Eldridge Investment Advisors, Inc.

$426 Million
Q3 2024

A detailed history of Eldridge Investment Advisors, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Eldridge Investment Advisors, Inc. holds 9,637 shares of ABBV stock, worth $1.61 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

9,637

Previous 9,633 0.04%

Holding current value

$1.61 Million

Previous $1.65 Million 15.19%

% of portfolio

0.45%

Previous 0.42%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$163.84 - $199.33 $655 - $797	4 Added 0.04%	9,637 $1.9 Million
Q2 2024 Aug 01, 2024	BUY	$154.79 - $180.76 $94,267 - $110,082	609 Added 6.75%	9,633 $1.65 Million
Q1 2024 May 10, 2024	BUY	$159.82 - $182.1 $5,274 - $6,009	33 Added 0.37%	9,024 $1.64 Million
Q4 2023 Feb 06, 2024	SELL	$137.6 - $154.97 $13,072 - $14,722	-95 Reduced 1.05%	8,991 $1.39 Million
Q3 2023 Nov 06, 2023	BUY	$133.59 - $154.65 $534 - $618	4 Added 0.04%	9,086 $1.35 Million
Q2 2023 Aug 03, 2023	SELL	$132.51 - $164.9 $11,263 - $14,016	-85 Reduced 0.93%	9,082 $1.22 Million
Q1 2023 May 12, 2023	BUY	$144.61 - $166.54 $723 - $832	5 Added 0.05%	9,167 $1.46 Million
Q4 2022 Feb 03, 2023	SELL	$138.31 - $165.87 $1,106 - $1,326	-8 Reduced 0.09%	9,162 $1.48 Million
Q3 2022 Nov 10, 2022	BUY	$134.21 - $153.93 $59,723 - $68,498	445 Added 5.1%	9,170 $1.23 Million
Q2 2022 Aug 11, 2022	BUY	$137.62 - $174.96 $550 - $699	4 Added 0.05%	8,725 $1.34 Million
Q1 2022 May 10, 2022	SELL	$131.98 - $163.75 $5,147 - $6,386	-39 Reduced 0.45%	8,721 $1.41 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $537 - $679	5 Added 0.06%	8,760 $1.19 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $532 - $603	5 Added 0.06%	8,755 $944,000
Q2 2021 Aug 05, 2021	BUY	$105.21 - $117.21 $420 - $468	4 Added 0.05%	8,750 $986,000
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $511 - $563	5 Added 0.06%	8,746 $946,000
Q4 2020 Feb 11, 2021	BUY	$80.49 - $108.67 $402 - $543	5 Added 0.06%	8,741 $937,000
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $257 - $302	3 Added 0.03%	8,736 $765,000
Q2 2020 Aug 07, 2020	BUY	$73.37 - $98.18 $586 - $785	8 Added 0.09%	8,733 $857,000
Q1 2020 May 08, 2020	BUY	$64.5 - $97.79 $322 - $488	5 Added 0.06%	8,725 $665,000
Q4 2019 Feb 03, 2020	BUY	$72.13 - $90.25 $288 - $361	4 Added 0.05%	8,720 $772,000
Q3 2019 Nov 01, 2019	BUY	$62.98 - $75.72 $440 - $530	7 Added 0.08%	8,716 $660,000
Q2 2019 Jul 29, 2019	BUY	$65.7 - $83.98 $3,153 - $4,031	48 Added 0.55%	8,709 $633,000
Q1 2019 Apr 24, 2019	BUY	$77.14 - $90.79 $385 - $453	5 Added 0.06%	8,661 $698,000
Q4 2018 Jan 24, 2019	BUY	$77.85 - $96.01 $673,869 - $831,062	8,656 New	8,656 $798,000

Others Institutions Holding ABBV

# of Institutions

3,846

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $295B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eldridge Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Eldridge Investment Advisors, Inc. with notifications on news.

Account

Eldridge Investment Advisors, Inc. Abb Vie Inc. Transaction History